Dr. Nadeem U Rahman , MD
Urology • Clovis, CA
782 Medical Center Drive E Suite 311
Clovis, CA 93611
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 15, 2006; this date does not establish years in practice.
-
Published CMS data list 167,771 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1071 — Injection, testosterone cypionate, 1 mg: 158,460 service units.
- 81003 — Automated urinalysis test: 2,078 service units.
- 99214 — Established patient outpatient office visit: 2,031 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 41 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,036 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 595 prescription fills, including refills.
- Finasteride — 335 prescription fills, including refills.
- Nitrofurantoin Mono-Macro (Nitrofurantoin Monohyd/M-Cryst) — 184 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 26 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: 1,340. Middle half: 505 to 3,668.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 178,462 in 2020 to 167,771 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
782 Medical Center Drive E Suite 311
Clovis, CA 93611
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Fresno, CA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: California Cancer Associates For Research And Excellence Inc; Community Health Partners. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Duke University School Of Medicine
1999
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,387 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $679,841 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $522,089 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
4,409 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$883,144 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,284.38 across 54 records.
By nature of payment
- Food and Beverage: $1,086.38 across 52 records.
- Education: $198.00 across 2 records.
Reporting-company totals (3 largest of 18)
- Astellas Pharma US Inc: $285.13 across 7 records.
- Sumitomo Pharma America, Inc.: $176.41 across 9 records.
- Antares Pharma, Inc.: $155.80 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
27 years (graduated 1999)
CMS Doctors and Clinicians data list 1999 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Rahman has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Rahman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Clovis and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: 1,340. Middle half: 505 to 3,668.
Too few clinicians listed under Urology in Clovis have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: $142,810. Middle half: $55,515 to $285,331.
Too few clinicians listed under Urology in Clovis have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in California (2024, 779 clinicians with data). Median for this group: $105,800. Middle half: $41,733 to $215,765.
Too few clinicians listed under Urology in Clovis have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Urology in California (2024, 1,070 clinicians with data). Median for this group: 911. Middle half: 244 to 1,758.
Too few clinicians listed under Urology in Clovis have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in California (2024, 1,070 clinicians with data). Median for this group: $77,401. Middle half: $13,099 to $231,076.
Too few clinicians listed under Urology in Clovis have Medicare Part D data for 2024 to compare.
4 active clinicians are listed under Urology with a practice address in Clovis, CA (1,524 in California).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 178,462 in 2020 and 167,771 in 2024.
- 2020: 178,462
- 2021: 206,986
- 2022: 206,387
- 2023: 212,089
- 2024: 167,771
-
Medicare-allowed amount
Medicare-allowed amount decreased 14% from $791,167 in 2020 to $679,841 in 2024.
- 2020: $791,167
- 2021: $777,412
- 2022: $729,028
- 2023: $724,231
- 2024: $679,841
-
Paid by Medicare
Paid by Medicare decreased 13% from $600,646 in 2020 to $522,089 in 2024.
- 2020: $600,646
- 2021: $590,836
- 2022: $546,163
- 2023: $556,362
- 2024: $522,089
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 23% from 2,656 in 2020 to 2,036 in 2024.
- 2020: 2,656
- 2021: 2,348
- 2022: 2,195
- 2023: 2,117
- 2024: 2,036
-
30-day fills
30-day fills decreased 19% from 5,446 in 2020 to 4,409 in 2024.
- 2020: 5,446
- 2021: 5,119
- 2022: 4,806
- 2023: 4,560
- 2024: 4,409
-
Part D drug cost
Part D drug cost increased 255% from $248,686 in 2020 to $883,144 in 2024.
- 2020: $248,686
- 2021: $248,044
- 2022: $225,892
- 2023: $277,097
- 2024: $883,144
-
Industry payments (Open Payments)
Industry payments (Open Payments) varied from year to year: $1,297.50 in 2021 and $1,284.38 in 2025.
- 2021: $1,297.50
- 2022: $8,661.68
- 2023: $27,462.27
- 2024: $1,784.67
- 2025: $1,284.38
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 54 records totaling $1,284.38.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| HealthTronics Stone Solutions, LLC |
Food and Beverage
Cash or cash equivalent
|
Dornier MedTech | General | $109.19 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $99.00 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
— | General | $99.00 |
| C. R. Bard, Inc. & Subsidiaries |
Food and Beverage
In-kind items and services
|
Bard Urinary Drainage Bag | General | $35.83 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $33.68 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $32.65 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $30.65 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $29.20 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.04 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $26.84 |
| Valencia Technologies Corporation |
Food and Beverage
Cash or cash equivalent
|
eCoin Device Kit | General | $26.26 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $24.83 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $24.22 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.11 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $23.97 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $23.76 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $23.75 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $23.43 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $22.89 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $22.57 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $22.13 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $22.05 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $21.71 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $21.54 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $21.03 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1071
Injection, testosterone cypionate, 1 mg
|
158,460 | 63 | $0.20 | $0.02 |
|
81003
Automated urinalysis test
|
2,078 | 1,024 | $9.00 | $2.19 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
2,031 | 1,056 | $404.67 | $130.07 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
988 | 653 | $77.78 | $11.97 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
609 | 467 | $49.00 | $16.33 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
588 | 12 | $179.00 | $56.93 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
571 | 433 | $284.99 | $92.54 |
|
96372
Injection of drug or substance under skin or into muscle
|
496 | 67 | $68.89 | $14.82 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
240 | 41 | $4037.26 | $177.63 |
|
51700
Simple bladder irrigation and/or instillation
|
236 | 92 | $251.57 | $77.17 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
206 | 172 | $755.36 | $250.32 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
181 | 181 | $518.16 | $168.46 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
130 | 56 | $38.24 | $2.57 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
118 | 25 | $37.00 | $0.45 |
|
64566
Insertion of lower leg neurostimulator electrode
|
88 | 13 | $410.00 | $122.68 |
|
50590
Shock wave crushing of kidney stones
|
83 | 62 | $2345.81 | $558.35 |
|
52332
Insertion of stent in ureter using an endoscope
|
77 | 59 | $1597.55 | $80.33 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
74 | 62 | $286.00 | $70.42 |
|
J1885
Injection, ketorolac tromethamine, per 15 mg
|
56 | 16 | $34.00 | $0.68 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
43 | 36 | $80.63 | $24.15 |
|
51702
Simple insertion of temporary bladder tube
|
41 | 23 | $204.00 | $64.72 |
|
55700
Biopsy of prostate gland
|
36 | 36 | $796.00 | $123.17 |
|
76872
Ultrasound scan of pelvic region through rectum
|
34 | 34 | $105.00 | $32.32 |
|
51741
Electronic assessment of bladder emptying
|
30 | 30 | $184.00 | $8.21 |
|
77021
Review by radiologist of mri guidance for needle placement
|
30 | 30 | $1497.00 | $70.17 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 595 | 50,047 | $11,656.77 | 245 |
| Finasteride | Finasteride | 335 | 28,169 | $4,763.90 | 139 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 184 | 2,846 | $3,475.06 | 146 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 131 | 824 | $1,010.52 | 102 |
| Gemtesa | Vibegron | 113 | 5,647 | $89,680.41 | 30 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 112 | 926 | $423.42 | 100 |
| Myrbetriq | Mirabegron | 88 | 6,793 | $105,159.03 | 38 |
| Dutasteride | Dutasteride | 51 | 4,590 | $1,624.39 | 22 |
| Terazosin Hcl | Terazosin Hcl | 48 | 4,130 | $606.49 | 20 |
| Erleada | Apalutamide | 43 | 1,290 | $592,874.96 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | 1,833 | $1,137.49 | 22 |
| Bicalutamide | Bicalutamide | 35 | 1,290 | $546.51 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 33 | 2,548 | $1,425.66 | 18 |
| Cephalexin | Cephalexin | 26 | 229 | $100.40 | 22 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | 674 | $526.10 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | 1,980 | $243.38 | — |
| Xyosted | Testosterone Enanthate | 22 | 1,106 | $23,682.43 | — |
| Estradiol | Estradiol | 21 | 774 | $1,492.24 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | 82 | $125.76 | 16 |
| Pentoxifylline | Pentoxifylline | 16 | 997 | $504.99 | — |
| Silodosin | Silodosin | 16 | 1,440 | $1,524.36 | — |
| Tadalafil | Tadalafil | 14 | 1,260 | $1,229.08 | — |
| Orgovyx | Relugolix | 14 | 420 | $37,762.48 | — |
| Testosterone Cypionate | Testosterone Cypionate | 12 | 574 | $757.05 | — |
| Desmopressin Acetate | Desmopressin Acetate | 12 | 687 | $733.61 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-12-04NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20081013000396
CA
2769439199
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
California Cancer Associates For Research And Excellence Inc
782 Medical Ctr Dr E, Clovis, CA 936116892
Phone: 5594724600
Community Health Partners
6107 N Fresno St, Fresno, CA 937108609
Phone: 5596037700
Community Health Partners
45 E River Park Pl W, Fresno, CA 937201565
Community Health Partners
45 E River Park Pl W, Fresno, CA 937201565
Phone: 5593200530
Secondary Practice Locations
7130 N Millbrook Ave
Fresno, CA 937203347
Phone: 5593261222
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at PO BOX 25100, FRESNO, CA 937295100
Registered at 782 MEDICAL CENTER DR E STE 311, CLOVIS, CA 936116892 (Tel: 5594724606)
Registered at 782 MEDICAL CENTER DRIVE E SUITE 311, CLOVIS, CA 93611 (Tel: 5594724606)
Registered at 782 MEDICAL CENER DRIVE E SUITE 361, CLOVIS, CA 93611 (Tel: 5594724606)
Urology (license number reported to NPPES: CA A74920)
Registered at 782 MEDICAL CENTER DR E STE 311, CLOVIS, CA 936116892 (Tel: 5594724600)
Registered at PO BOX 28949, FRESNO, CA 937298949 (Tel: 5592284200)
Recorded as NADEEM RAHMAN, MD
NPI status registered as active in NPPES database
Registered at 6113 N FRESNO ST, STE 101, FRESNO, CA 937105207 (Tel: 5594382777)
Registered at 6113 N FRESNO ST, STE 101, FRESNO, CA 937105207 (Tel: 5594382777)
Recorded as NADEEM RAHMAN, M.D.
Urology (license number reported to NPPES: AZ 33530)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Clovis
Healthcare providers in ClovisMailing Address
Po Box 25100
Fresno, CA 937295100